Caliper Spins Off $25M Subsidiary Amphora: Major LabChip Customer Technology | GenomeWeb

Microfluidics leader Caliper Technologies has spun out a $25 million startup Amphora, which will use Caliper’s LabChip technology to develop a chemical genomics database for pharmaceutical drug discovery, the company said.

Amphora, which is 25 percent owned by Mountain View, Calif.-based Caliper, is to be headed up by Martin Haslanger, the former president of Sphinx Laboratories at Eli Lilly. Bill Jansens, also formerly of Sphinx, will serve as vice president, operations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.